Detalles de la búsqueda
1.
Periodic, partial inhibition of IkappaB Kinase beta-mediated signaling yields therapeutic benefit in preclinical models of rheumatoid arthritis.
J Pharmacol Exp Ther
; 331(2): 349-60, 2009 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-19652024
2.
Discovery of brivanib alaninate ((S)-((R)-1-(4-(4-fluoro-2-methyl-1H-indol-5-yloxy)-5-methylpyrrolo[2,1-f][1,2,4]triazin-6-yloxy)propan-2-yl)2-aminopropanoate), a novel prodrug of dual vascular endothelial growth factor receptor-2 and fibroblast growth factor receptor-1 kinase inhibitor (BMS-540215).
J Med Chem
; 51(6): 1976-80, 2008 Mar 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-18288793
3.
Mapping the central effects of (±)-ketamine and traxoprodil using pharmacological magnetic resonance imaging in awake rats.
J Psychopharmacol
; 32(2): 146-155, 2018 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-29378483
4.
Synthesis and Biologic Evaluation of a Novel 18F-Labeled Adnectin as a PET Radioligand for Imaging PD-L1 Expression.
J Nucl Med
; 59(3): 529-535, 2018 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-29025984
5.
Bruton's tyrosine kinase inhibitor BMS-986142 in experimental models of rheumatoid arthritis enhances efficacy of agents representing clinical standard-of-care.
PLoS One
; 12(7): e0181782, 2017.
Artículo
en Inglés
| MEDLINE | ID: mdl-28742141
6.
Discovery and evaluation of N-cyclopropyl- 2,4-difluoro-5-((2-(pyridin-2-ylamino)thiazol-5- ylmethyl)amino)benzamide (BMS-605541), a selective and orally efficacious inhibitor of vascular endothelial growth factor receptor-2.
J Med Chem
; 49(13): 3766-9, 2006 Jun 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-16789733
7.
Discovery and preclinical studies of (R)-1-(4-(4-fluoro-2-methyl-1H-indol-5-yloxy)-5- methylpyrrolo[2,1-f][1,2,4]triazin-6-yloxy)propan- 2-ol (BMS-540215), an in vivo active potent VEGFR-2 inhibitor.
J Med Chem
; 49(7): 2143-6, 2006 Apr 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-16570908
8.
Small Molecule Reversible Inhibitors of Bruton's Tyrosine Kinase (BTK): Structure-Activity Relationships Leading to the Identification of 7-(2-Hydroxypropan-2-yl)-4-[2-methyl-3-(4-oxo-3,4-dihydroquinazolin-3-yl)phenyl]-9H-carbazole-1-carboxamide (BMS-935177).
J Med Chem
; 59(17): 7915-35, 2016 09 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-27531604
9.
Design, synthesis, and evaluation of orally active 4-(2,4-difluoro-5-(methoxycarbamoyl)phenylamino)pyrrolo[2,1-f][1,2,4]triazines as dual vascular endothelial growth factor receptor-2 and fibroblast growth factor receptor-1 inhibitors.
J Med Chem
; 48(12): 3991-4008, 2005 Jun 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-15943473
10.
Antitumor and antiangiogenic activities of BMS-690514, an inhibitor of human EGF and VEGF receptor kinase families.
Clin Cancer Res
; 17(12): 4031-41, 2011 Jun 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-21531814
11.
The antiangiogenic activity in xenograft models of brivanib, a dual inhibitor of vascular endothelial growth factor receptor-2 and fibroblast growth factor receptor-1 kinases.
Mol Cancer Ther
; 9(2): 369-78, 2010 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-20103604
Resultados
1 -
11
de 11
1
Próxima >
>>